Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer's disease dispensed by the Brazilian public health system - 2008 to 2014: a nation-wide analysis

Moraes FS, Souza MLC, Lucchetti G, Lucchetti ALG.

Arq Neuropsiquiatr. 2018 Jul;76(7):444-451. doi: 10.1590/0004-282X20180064.

Stem cell- and gene-based therapies as potential candidates in Alzheimer's therapy

Hosseini SA, Mohammadi R, Noruzi S, Mohamadi Y, Azizian M, Mousavy SM, Ghasemi F, Hesari A, Sahebkar A, Salarinia R, Aghdam AM, Mirzaei H.

J Cell Biochem. 2018 Nov;119(11):8723-8736. doi: 10.1002/jcb.27202. Epub 2018 Aug 3.

Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain

Hey JA, Kocis P, Hort J, Abushakra S, Power A, Vyhnálek M, Yu JY, Tolar M.

CNS Drugs. 2018 Sep;32(9):849-861. doi: 10.1007/s40263-018-0554-0.

Differential effects of cognition-focused interventions for people with Alzheimer's disease: A meta-analysis

Oltra-Cucarella J, Ferrer-Cascales R, Clare L, Morris SB, Espert R, Tirapu J, Sánchez-SanSegundo M.

Neuropsychology. 2018 Sep;32(6):664-679. doi: 10.1037/neu0000449. Epub 2018 Aug 6.

A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease

Ajith TA.

Curr Clin Pharmacol. 2018;13(4):252-260. doi: 10.2174/1574884713666180807145648.

Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study

Colombo D, Caltagirone C, Padovani A, Sorbi S, Spalletta G, Simoni L, Ori A, Zagni E.

J Womens Health (Larchmt). 2018 Nov;27(11):1368-1377. doi: 10.1089/jwh.2017.6420. Epub 2018 Sep 8.

Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis

Duan Y, Lu L, Chen J, Wu C, Liang J, Zheng Y, Wu J, Rong P, Tang C.

BMC Geriatr. 2018 Aug 7;18(1):175. doi: 10.1186/s12877-018-0864-6.

Cognitive Therapy for Dementia Patients: A Systematic Review

Carrion C, Folkvord F, Anastasiadou D, Aymerich M.

Dement Geriatr Cogn Disord. 2018;46(1-2):1-26. doi: 10.1159/000490851. Epub 2018 Aug 9.

Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives

de Castro AA, da Cunha EFF, Pereira AF, Soares FV, Leal DHS, Kuca K, Ramalho TC.

Curr Alzheimer Res. 2018;15(12):1161-1178. doi: 10.2174/1567205015666180813150703.

The effects of physical exercise on executive function in community-dwelling older adults living with Alzheimer's-type dementia: A systematic review

Guitar NA, Connelly DM, Nagamatsu LS, Orange JB, Muir-Hunter SW.

Ageing Res Rev. 2018 Nov;47:159-167. doi: 10.1016/j.arr.2018.07.009. Epub 2018 Aug 10.

Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease

Tandon A, Singh SJ, Chaturvedi RK.

Biomed Res Int. 2018 Jul 12;2018:1483791. doi: 10.1155/2018/1483791. eCollection 2018.

Beneficial Effect of Multidomain Cognitive Training on the Neuropsychological Performance of Patients with Early-Stage Alzheimer's Disease

Nousia A, Siokas V, Aretouli E, Messinis L, Aloizou AM, Martzoukou M, Karala M, Koumpoulis C, Nasios G, Dardiotis E.

Neural Plast. 2018 Jul 11;2018:2845176. doi: 10.1155/2018/2845176. eCollection 2018.

Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study

Salloway S, Marshall GA, Lu M, Brashear HR.

Curr Alzheimer Res. 2018;15(13):1231-1243. doi: 10.2174/1567205015666180821114813.

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study

Timmers M, Streffer JR, Russu A, Tominaga Y, Shimizu H, Shiraishi A, Tatikola K, Smekens P, Börjesson-Hanson A, Andreasen N, Matias-Guiu J, Baquero M, Boada M, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.

Alzheimers Res Ther. 2018 Aug 23;10(1):85. doi: 10.1186/s13195-018-0415-6.

Current understanding of Alzheimer's disease diagnosis and treatment

Weller J, Budson A.

F1000Res. 2018 Jul 31;7:F1000 Faculty Rev-1161. doi: 10.12688/f1000research.14506.1. eCollection 2018.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias